Psychopharmacology and Psychiatry Updates
By Psychopharmacology Institute
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Psychopharmacology Institute
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 128
Reviews: 0
Episodes: 100
Description
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
| Episode | Date |
|---|---|
|
Beyond Weight Loss: Can Semaglutide Treat Alcohol Use Disorder?
|
Apr 01, 2026 |
|
Managing Lithium's Renal Risks: Evidence-Based Strategies
|
Mar 27, 2026 |
|
Cariprazine for Bipolar Illness in the Elderly: What the Data Show
|
Mar 22, 2026 |
|
Lithium Essentials: Monitoring, Drug Interactions, and Safety
|
Mar 17, 2026 |
|
ADHD Stimulants: Clinical Safeguards Against Misuse and Diversion
|
Mar 12, 2026 |
|
Staying Well: LAIs vs. Oral Medications in Cannabis-Induced Psychosis
|
Mar 07, 2026 |
|
Adult ADHD: Optimizing Stimulant Therapy
|
Mar 02, 2026 |
|
Semaglutide for Clozapine-Induced Weight Gain: The COaST Trial
|
Feb 25, 2026 |
|
Beyond Stimulants: Tailoring ADHD Treatment to Comorbidities
|
Feb 20, 2026 |
|
Beyond Standard Treatment: Exploring Pramipexole in Bipolar Depression
|
Feb 15, 2026 |
|
SERT Gene Testing: Separating Hype from Evidence
|
Feb 10, 2026 |
|
The SSRI-Anticoagulant Interaction: Evidence-Based Prescribing Strategies
|
Feb 05, 2026 |
|
Pharmacogenetic Testing in Psychiatry: Help or Hype?
|
Jan 31, 2026 |
|
Lurasidone: Managing Bipolar Depression with Comorbid Anxiety
|
Jan 26, 2026 |
|
GLP-1 Agonists vs. Antipsychotic Weight Gain
|
Jan 21, 2026 |
|
Pharmacogenetics-Guided Dosing: Poor vs. Rapid Metabolizers
|
Jan 16, 2026 |
|
INTEGRATE Guidelines: Standardizing Schizophrenia Pharmacotherapy
|
Jan 11, 2026 |
|
Pharmacogenetics: Separating Science from Marketing
|
Jan 06, 2026 |
|
Lithium vs. Quetiapine: Augmenting Treatment-Resistant Depression
|
Jan 01, 2026 |
|
Postpartum Psychopharmacology: Breastfeeding and Bipolar Disorder
|
Dec 27, 2025 |
|
Fast-Acting Relief: Neurosteroids for Postpartum Depression
|
Dec 22, 2025 |
|
Lumateperone for Depression with Mixed Features: New Evidence
|
Dec 17, 2025 |
|
Antidepressants and Breastfeeding: Safety Considerations
|
Dec 12, 2025 |
|
QT Prolongation and Psychiatric Medication: A Cardiac Safety Update
|
Dec 07, 2025 |
|
Distinguishing Postpartum OCD from Psychosis
|
Dec 02, 2025 |
|
Do SSRI Side Effects Improve Over Time?
|
Nov 27, 2025 |
|
Beyond Lithium Monotherapy: Evidence-Based Augmentation in Acute Mania
|
Nov 22, 2025 |
|
Choosing First-Line Antipsychotics: Considering Violence
|
Nov 17, 2025 |
|
Beyond Antipsychotics: Using Lithium in Mania
|
Nov 12, 2025 |
|
Trazodone vs. Doxepin vs. Melatonin: Comparing Alternatives for Sleep
|
Nov 07, 2025 |
|
Beyond Monotherapy: Mixed Episode Management
|
Nov 02, 2025 |
|
Old Drug, New Perspectives: Disulfiram's and Addiction Medicine
|
Oct 28, 2025 |
|
Quetiapine vs. Lithium in Mixed Bipolar States
|
Oct 23, 2025 |
|
Psychedelic-Assisted Therapy: Redefining Treatment
|
Oct 18, 2025 |
|
Lurasidone's Therapeutic Window: Is Less More?
|
Oct 13, 2025 |
|
Beyond Black Box Warnings: Choosing Antipsychotics in Dementia
|
Oct 08, 2025 |
|
SSRIs and Psychedelics: Drug Interactions
|
Oct 03, 2025 |
|
Standard vs. High Doses: Rethinking Bipolar Maintenance Treatment
|
Sep 28, 2025 |
|
Psychedelics and Brain Networks
|
Sep 23, 2025 |
|
LAIs vs Oral Antipsychotics: Mortality Data and Clinical Impact
|
Sep 18, 2025 |
|
The Science Behind Psychedelic Therapy
|
Sep 13, 2025 |
|
Which Antidepressant Causes the Most Weight Gain?
|
Sep 08, 2025 |
|
Lisdexamfetamine for Binge Eating Disorder
|
Sep 03, 2025 |
|
Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder
|
Aug 29, 2025 |
|
Antidepressants vs. Anticonvulsants for Binge Eating
|
Aug 24, 2025 |
|
Lithium Levels: Finding the Right Therapeutic Target
|
Aug 19, 2025 |
|
Antidepressants Beyond Depression: Applications in Bulimia Nervosa
|
Aug 14, 2025 |
|
Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution
|
Aug 09, 2025 |
|
Monthly Injections, Long-Term Recovery: Naltrexone for OUD
|
Aug 04, 2025 |
|
Antipsychotics and Aspiration Risk
|
Jul 30, 2025 |
|
Buprenorphine, Methadone, and Naltrexone: Helping Patients with OUD Decide
|
Jul 25, 2025 |
|
Managing OUD with Buprenorphine: Clinical Pearls
|
Jul 20, 2025 |
|
Valproate Weight Gain: Do Lower Doses Help?
|
Jul 15, 2025 |
|
Methadone for Opioid Use Disorder
|
Jul 10, 2025 |
|
Clozapine and Compulsions: New Research On An Old Side Effect
|
Jul 05, 2025 |
|
Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
|
Jun 30, 2025 |
|
Beyond Tapering: Supporting Patients Through Benzodiazepine Discontinuation
|
Jun 25, 2025 |
|
Beyond Blood Counts: Clozapine, Bowel Obstruction, and Pneumonia
|
Jun 20, 2025 |
|
Demystifying Benzodiazepine Deprescribing: Smart Approaches to Tapering
|
Jun 15, 2025 |
|
Lithium: Implications for Bone Health
|
Jun 10, 2025 |
|
Tapering with Care: Benzodiazepine Discontinuation
|
Jun 05, 2025 |
|
Dementia Risk and Vitamin D
|
May 31, 2025 |
|
Beyond Benzos: Strategies for Successful Deprescribing
|
May 26, 2025 |
|
Motherhood and Medication: LAIs for Women with Schizophrenia
|
May 21, 2025 |
|
Benzodiazepines in High-Risk Populations
|
May 16, 2025 |
|
Benzodiazepines: Understanding Physical Dependence vs. Addiction
|
May 11, 2025 |
|
Beyond Metformin: Probiotics and Antipsychotic Weight Gain
|
May 06, 2025 |
|
What Every Clinician Should Know About the Risks of Benzodiazepines
|
May 01, 2025 |
|
Making an Exit Plan: Navigating Antidepressant Discontinuation
|
Apr 26, 2025 |
|
Clinical Pearls for Selecting the Right Benzodiazepine
|
Apr 21, 2025 |
|
TMS for Depression: From Clinical Trials to Results
|
Apr 16, 2025 |
|
A Guide to Selecting TMS Candidates
|
Apr 11, 2025 |
|
Rethinking Clozapine Monitoring: 22 Years of Data
|
Apr 06, 2025 |
|
Understanding TMS in OCD: Evidence and Practice
|
Apr 01, 2025 |
|
Breaking Down the TRAILBLAZER-ALZ 2 Trial
|
Mar 27, 2025 |
|
Long-term Benzo Use: What The Data Really Show
|
Mar 22, 2025 |
|
Navigating TMS Side Effects: A Practical Guide
|
Mar 17, 2025 |
|
SSRIs and Anticoagulants: Navigating Bleeding Risk
|
Mar 12, 2025 |
|
Lamotrigine and the Heart: What You Need to Know
|
Mar 07, 2025 |
|
After the Last Dose: Understanding Antipsychotic Discontinuation
|
Mar 02, 2025 |
|
Understanding Lamotrigine's Cardiac Effects
|
Feb 25, 2025 |
|
Rethinking Falls: Are Sleep Medications Really to Blame?
|
Feb 20, 2025 |
|
Navigating Lamotrigine's Side Effects
|
Feb 15, 2025 |
|
Iloperidone in Bipolar Disorder: A New Treatment Option?
|
Feb 10, 2025 |
|
Lamotrigine: Pearls for Prescribing
|
Feb 05, 2025 |
|
Beyond Benzos: New Frontiers in Agitation Management
|
Jan 31, 2025 |
|
KarXT: A New Dawn in Antipsychotic Treatment
|
Jan 26, 2025 |
|
Rethinking Agitation Management: From Force to Partnership
|
Jan 21, 2025 |
|
COVID Brain Fog: Repurposing Famotidine
|
Jan 16, 2025 |
|
Beyond Restraints: De-Escalation in Behavioral Emergencies
|
Jan 11, 2025 |
|
Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial
|
Jan 06, 2025 |
|
Unraveling Agitation: Mania vs. Substance Use
|
Jan 01, 2025 |
|
Pushing the Boundaries: Exploring High-Dose Antipsychotics
|
Dec 27, 2024 |
|
The Psychodynamic Prescriber
|
Dec 22, 2024 |
|
From Inpatient to Outpatient: Initiating Benzodiazepine Tapering
|
Dec 17, 2024 |
|
The Power of Alliance in Psychopharmacology
|
Dec 12, 2024 |
|
Antipsychotics in Youth: Balancing Metabolic Risk
|
Dec 07, 2024 |
|
The Double-Edged Sword of Biological Explanations in Mental Health
|
Dec 02, 2024 |
|
New Insights into Psychiatric and Cardiovascular Comorbidity
|
Nov 27, 2024 |
|
Beyond the Pill: The Psychology of Psychopharmacology
|
Nov 22, 2024 |